In the cohort of Brazilian paediatric ALL patients genotyped by our group (see above), the MAFs of TPMT variants were 4.9% (rs1142345), 2.4% (rs1800460) and 1.4% (rs1800462). This evidence concerns the gene TPMT and acute lymphoblastic leukemia.